13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: not found
          • Article: not found

          World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

          (2013)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.

            The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

              The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2018 informed new recommendations. These include additional focus on social determinants of health, the health care system, and physical activity behaviors, including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease. After a summary listing of consensus recommendations, practical tips for implementation are provided.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Diabetes, Obesity and Metabolism
                Diabetes Obesity Metabolism
                Wiley
                1462-8902
                1463-1326
                June 2023
                March 12 2023
                June 2023
                : 25
                : 6
                : 1658-1667
                Affiliations
                [1 ] Department of Translational Medical Sciences Federico II University School of Medicine Naples Italy
                [2 ] IRCCS Multimedica Milan Italy
                [3 ] Novo Nordisk A/S Søborg Denmark
                [4 ] Diabetic Clinic, USL Umbria1 Perugia Territorial Health Structure Perugia Italy
                [5 ] Novo Nordisk spa Rome Italy
                [6 ] Diabetes Care Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
                [7 ] Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases University of Bari Aldo Moro Bari Italy
                Article
                10.1111/dom.15020
                36789682
                e7199c0f-e5d0-4bae-a4f7-a24fd525731f
                © 2023

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                History

                Comments

                Comment on this article